Paper20054037
Erythropoiesis-stimulating agents--time for a reevaluation.
Unger EF and 3 others. N Engl J Med, 2010. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. Erythropoiesis-stimulating agents--time for a reevaluation. Papers, record 20054037. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20054037
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia | Major topic |
| Cardiovascular Diseases | Major topic |
| Hematinics | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Darbepoetin alfa | |
| Diabetes Mellitus, Type 2 | |
| Epoetin Alfa | |
| Erythropoietin | |
| Hemoglobins | |
| Humans | |
| Recombinant Proteins |
Source PubMed
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 20445190 | Reevaluating erythropoiesis-stimulating agents. | https://conductscience.org/library/papers/20445190 | PubMed |
| Comment in | 20449880 | Reevaluating erythropoiesis-stimulating agents. | https://conductscience.org/library/papers/20449880 | PubMed |
| Comment in | 20449881 | Reevaluating erythropoiesis-stimulating agents. | https://conductscience.org/library/papers/20449881 | PubMed |
| Comment in | 21058263 | Erythropoietin and the truths of science. | https://conductscience.org/library/papers/21058263 | PubMed |
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42218466 | Machine learning prediction of long-term postoperative pneumonia risk: a retrospective cohort study. | BMC Med Inform Decis Mak | 2026 | https://conductscience.org/library/papers/42218466 | PubMed |
| 40508930 | The Efficacy and Safety of a Personalized Protocol Designed to Balance Hemoglobin Levels in Hemodialysis Patients as Led by Nephrology Clinical Nurse Specialists: An Intervention Study. | Healthcare (Basel) | 2025 | https://conductscience.org/library/papers/40508930 | PubMed |
| 39474732 | Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management. | Tuberc Respir Dis (Seoul) | 2025 | https://conductscience.org/library/papers/39474732 | PubMed |
| 39370259 | Roxadustat for Treating Anemia in Patients with Advanced Chronic Kidney Disease Not Undergoing Dialysis: A Retrospective Study. | Intern Med | 2025 | https://conductscience.org/library/papers/39370259 | PubMed |
| 37188016 | New horizons for reduction of blood use: Patient blood management. | Asian J Transfus Sci | 2023 | https://conductscience.org/library/papers/37188016 | PubMed |
| 36748065 | Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020. | Kidney Med | 2023 | https://conductscience.org/library/papers/36748065 | PubMed |
| 36443417 | Current Practices and Guidelines for Perioperative Blood Management in Post-Bariatric Body Contouring Surgery: A Comprehensive Review of Literature. | Aesthetic Plast Surg | 2023 | https://conductscience.org/library/papers/36443417 | PubMed |
| 36316853 | Effect of vitamin and mineral supplementation on nutritional status in children with chronic kidney disease: Protocol for a systematic review and meta-analysis. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/36316853 | PubMed |
| 35620020 | Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery. | Clin Interv Aging | 2022 | https://conductscience.org/library/papers/35620020 | PubMed |
| 35517793 | Dynamics of Erythroferrone Response to Erythropoietin in Rats. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35517793 | PubMed |
| 33732977 | Roxadustat for CKD-related Anemia in Non-dialysis Patients. | Kidney Int Rep | 2021 | https://conductscience.org/library/papers/33732977 | PubMed |
| 33198376 | Iron Therapy in Inflammatory Bowel Disease. | Nutrients | 2020 | https://conductscience.org/library/papers/33198376 | PubMed |
| 32996284 | Population Pharmacodynamic Modeling of Epoetin Alfa in End-Stage Renal Disease Patients Receiving Maintenance Treatment Using Bayesian Approach. | CPT Pharmacometrics Syst Pharmacol | 2020 | https://conductscience.org/library/papers/32996284 | PubMed |
| 32699623 | Low hemoglobin at hemodialysis initiation: an international study of anemia management and mortality in the early dialysis period. | Clin Kidney J | 2020 | https://conductscience.org/library/papers/32699623 | PubMed |
| 32248614 | Absorption, distribution, metabolism and excretion of molidustat in healthy participants. | Basic Clin Pharmacol Toxicol | 2020 | https://conductscience.org/library/papers/32248614 | PubMed |
| 31680856 | The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts. | Front Mol Neurosci | 2019 | https://conductscience.org/library/papers/31680856 | PubMed |
| 31548896 | Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease? | BMJ Open Respir Res | 2019 | https://conductscience.org/library/papers/31548896 | PubMed |
| 31203241 | Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies. | BMJ Open | 2019 | https://conductscience.org/library/papers/31203241 | PubMed |
| 30953333 | Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial. | Adv Ther | 2019 | https://conductscience.org/library/papers/30953333 | PubMed |
| 30049300 | Individualized anemia management in a dialysis facility - long-term utility as a single-center quality improvement experience . | Clin Nephrol | 2018 | https://conductscience.org/library/papers/30049300 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20054037
GET https://conductscience.org/api/papers/v1/20054037/cited_by?page=2